Hinge Health, Inc. (HNGE) — Analyst outlook / Analyst consensus target is. Based on 12 analyst ratings, the consensus is bullish — 12 Buy.
The consensus price target is $56.88 (low: $50.00, high: $68.00), representing an upside of 46.7% from the current price $38.78.
Analysts estimate Earnings Per Share (EPS) of $-19.47 and revenue of $0.48B for the next fiscal year.
Earnings Per Share (EPS) track record: 2025: actual $-5.36 vs est $1.45 (missed -469.4%). Analyst accuracy: 0%.
HNGE Stock — 12-Month Price Forecast
$56.88
▲ +46.67% Upside
Average Price Target
Based on 12 Wall Street analysts offering 12-month price targets for Hinge Health, Inc., the average price target is $56.88, with a high forecast of $68.00, and a low forecast of $50.00.
The average price target represents a +46.67% change from the last price of $38.78.
Highest Price Target
$68.00
Average Price Target
$56.88
Lowest Price Target
$50.00
HNGE Analyst Ratings
Buy
Based on 12 analysts giving stock ratings to Hinge Health, Inc. in the past 3 months
EPS Estimates — HNGE
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.00
vs Est –$19.47
▲ 0.0% off
2025
Actual –$5.36
vs Est $1.45
▼ 127.1% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — HNGE
87%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.390B
vs Est $0.481B
▼ 23.2% off
2025
Actual $0.588B
vs Est $0.572B
▲ 2.6% off
Revenue Trend
Strong revenue growth over the period shown. Analysts forecast revenue contraction ahead.
